340B Drug Pricing Program - Alternative Access

Burrows Consulting has navigated countless healthcare providers through the FQHC/FQHC Look-Alike application and site visit processes. One of the major perks of participating in the Health Center Program (HCP) is access to the 340B Drug Pricing Program as a Covered Entity. In 2022, our firm began working with several healthcare providers seeking alternative eligibility and participation in the 340B Program through specializing in STD, HIV and Hepatitis care for vulnerable and at-risk populations in their community. Since then, Burrows Consulting has played an integral role in establishing STD clinics in multiple states for varying entity types, including organizations with a for-profit tax classification.

?

What is the 340B Drug Pricing Program?

The 340B Program turned 30 years old last year. Created in 1992 to ensure that at-risk, underserved, uninsured and other vulnerable populations have access to critical drugs. Decreasing cost barriers for eligible drugs have allowed providers to deliver better clinical outcomes.?

The 340B world has seen a large amount of controversy in recent years, ranging from manufacturers attempting to dismantle the Program through lobbying efforts and refusal to ship to contract pharmacies, third-party administrators heavily taxing the industry with software and providers exposed for poor allocation of revenue achieved through 340B drug cost savings. Remember, the primary objective of the Program is to spread scarce federal dollars to those with challenges accessing it.

What is an STD Clinic?

So called ‘STD Clinics’ ...Click here to check out the rest of the article on our website!